For the Inventor, By the Inventor

Enter assignee name

Madison, WI, United States of America

Mirus Bio Corporation

USPTO Granted Patents = 40

% Expired Patents = 50.0

EPO Patents = 4

Trademarks = 14

Forward Citations = 356

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Jon Asher Wolff (31 out of 97 patents)

Vladimir G Budker (27 out of 59 patents)

James E Hagstrom (26 out of 64 patents)

4. Sean D Monahan (17 out of 44 patents)

5. David B Rozema (13 out of 83 patents)

6. Paul Michael Slattum (13 out of 26 patents)

7. Vladimir S Trubetskoy (12 out of 33 patents)

8. Hans Herweijer (6 out of 12 patents)

9. Darren H Wakefield (4 out of 58 patents)

10. Julia Hegge (4 out of 9 patents)

11. So Wong (3 out of 19 patents)

12. Nicholas A A Rossi (3 out of 6 patents)

13. Alexander V Sokoloff (3 out of 5 patents)

14. Aaron G Loomis (3 out of 3 patents)

15. David L Lewis (2 out of 44 patents)

Core Competencies:

Transfection Reagents

Amphipathic Compounds

Gene Expression

Nucleic Acid Delivery

Polyampholytes

Drug Delivery

Polynucleotide Complexes

Intravascular Delivery

siRNA Compositions

Mammalian Cell Targeting

Labile Linkages

Micellar Systems

40 patents: Sort by Forward Citations

1. 11739174 - Cationic cyclic amine and amphipathic transfection reagents (2023-08-29),

2. 10619162 - Cationic cyclic amine and amphipathic transfection reagents (2020-04-14),

3. 9677077 - Cationic acrylamide copolymer transfection reagents (2017-06-13),

4. 8921448 - Transfection compositions using amphipathic compounds (2014-12-30),

5. 8129509 - Method for single-step attachment of a label to target molecules (2012-03-06),

6. 7601367 - Compositions and processes using siRNA, amphipathic compounds and polycations (2009-10-13),

7. 7491538 - Gene expression with covalently modified polynucleotides (2009-02-17),

8. 7476401 - Protein and peptide delivery to mammalian cells in vitro (2009-01-13),

9. 7439051 - Process for utilizing epitopes recognized by natural antibodies (2008-10-21),

10. 7435723 - Process for delivery of polynucleotides to the prostate (2008-10-14),

11. 7396919 - Charge reversal of polyion complexes (2008-07-08),

12. 7348453 - Labile linkage for compound delivery to a cell (2008-03-25),

13. 7326780 - Compounds and processes for single-pot attachment of a label to nucleic acid (2008-02-05),

14. 7262056 - Enhancing intermolecular integration of nucleic acids using integrator complexes (2007-08-28),

15. 7220400 - Compositions for delivering nucleic acids to cells (2007-05-22),

Mirus Bio Corporation is a leading biotechnology company specializing in the development and commercialization of innovative products for nucleic acid delivery, gene expression, and protein expression. With a focus on delivering high-quality reagents and exceptional technical support, Mirus Bio has become a trusted partner for researchers in academia, government, and the biopharmaceutical industry. Through cutting-edge technologies and a customer-centric approach, Mirus Bio continues to advance the field of molecular biology, enabling breakthrough discoveries and contributing to the development of novel therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Mirus Bio Corporation

40 Patents

#23 in Madison, WI

#217 in Wisconsin

#8,604 in US

#17,011 in the World

Madison, WI, United States of America

Mirus Bio Corporation

Forward Citations = 356

31 inventors:

Jon Asher Wolff (31 out of 97 patents)

Vladimir G Budker (27 out of 59 patents)

James E Hagstrom (26 out of 64 patents)

4. Sean D Monahan (17 out of 44 patents)

5. David B Rozema (13 out of 83 patents)

Please report any incorrect information to [email protected]

Loading…